Lombard Medical EVARF · USD

Its shares trade under the ticker EVARF. It has been listed since 25 April 2014. In the fiscal year to 31 December 2016, it reported revenue of $12.2m and a net loss of $31.0m. At that date it held total assets of $67.8m and shareholders' equity of $14.0m.

Lombard Medical, Inc. operates as a medical technology company. The company is headquartered in Didcot, Oxfordshire. The company went IPO on 2014-04-25. The firm specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The firm's Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The firm supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. The company also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.

Figures and description from our data supplier, not checked against the company's own report.

More about Lombard Medical →

We have not reported on Lombard Medical yet.

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.